Vascular Biogenics LtdVascular Biogenics Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Scroll down to the end of this page for potential risks for Vascular Biogenics Ltd based on sector, geography and size. The Disclosure rating includes 17 United Nations SDGs including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Peace, Justice & Strong Institutions'. This ESG assessment for Vascular Biogenics Ltd indicates the company's reporting of the UN SDGs.

Vascular Biogenics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 6.0, social score of 5.3 and governance score of 3.4.

SDG Transparency Score for Vascular Biogenics Ltd 
Low
0 - 3

5.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Vascular Biogenics Ltd 
6.0

Environmental

5.3

Social

3.4

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
958Provectus Biopharmaceuticals Inc
5.2
High
958Vectura Group Services Ltd
5.2
High
999Vascular Biogenics Ltd
5.1
High
999Aequus Pharmaceuticals Inc
5.1
High
999BioRestorative Therapies Inc
5.1
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Vascular Biogenics Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd offer flexible work?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Vascular Biogenics Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose water use targets?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Vascular Biogenics Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Vascular Biogenics Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Vascular Biogenics Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Vascular Biogenics Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Vascular Biogenics Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Vascular Biogenics Ltd
These potential risks are based on the size, segment and geographies of the company.

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

Sorry!

Failed to process!